Infinium Pharmachem Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 02:18 pm
13-11-2025 | 02:18 pm
Infinium PharmaChem's board approved consolidated financial results for the half-year ended September 30, 2025. Revenue from operations hit ₹84.05 Cr, with a profit of ₹6.52 Cr. The board also confirmed no deviation in fund utilization from IPO and preferential issues.
No comments yet. Be the first to comment!
